Gérald Gavory

619 total citations
16 papers, 386 citations indexed

About

Gérald Gavory is a scholar working on Molecular Biology, Oncology and Physiology. According to data from OpenAlex, Gérald Gavory has authored 16 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Oncology and 4 papers in Physiology. Recurrent topics in Gérald Gavory's work include RNA Interference and Gene Delivery (5 papers), Ubiquitin and proteasome pathways (4 papers) and Cancer-related Molecular Pathways (4 papers). Gérald Gavory is often cited by papers focused on RNA Interference and Gene Delivery (5 papers), Ubiquitin and proteasome pathways (4 papers) and Cancer-related Molecular Pathways (4 papers). Gérald Gavory collaborates with scholars based in United Kingdom, Switzerland and China. Gérald Gavory's co-authors include Shankar Balasubramanian, C. O'Dowd, Oliver Barker, Keeva McClelland, Matthew Helm, Timothy Harrison, Jakub Flasz, Natalie Page, Hugues Miel and Mark Isalan and has published in prestigious journals such as Nucleic Acids Research, Biochemistry and Cancer Research.

In The Last Decade

Gérald Gavory

15 papers receiving 383 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gérald Gavory United Kingdom	9	357	117	51	47	35	16	386
Ulf Eidhoff Switzerland	6	329 0.9×	161 1.4×	45 0.9×	29 0.6×	43 1.2×	8	388
John R. Ferguson United States	7	449 1.3×	86 0.7×	48 0.9×	44 0.9×	50 1.4×	9	541
Joanna Strachan United Kingdom	8	380 1.1×	139 1.2×	42 0.8×	13 0.3×	41 1.2×	14	407
Gertrude Zisser Austria	13	457 1.3×	146 1.2×	14 0.3×	9 0.2×	30 0.9×	16	517
Wanyi Hu United States	8	387 1.1×	180 1.5×	45 0.9×	9 0.2×	25 0.7×	19	439
Woo Suk Choi United States	7	281 0.8×	90 0.8×	21 0.4×	11 0.2×	17 0.5×	9	315
Andrei Shchebet Germany	6	360 1.0×	82 0.7×	20 0.4×	7 0.1×	28 0.8×	7	417
Audrey Furst France	8	573 1.6×	109 0.9×	16 0.3×	17 0.4×	38 1.1×	10	652
Kelly Chiang United Kingdom	8	395 1.1×	95 0.8×	17 0.3×	16 0.3×	27 0.8×	9	610
Lisa Hernandez‐Cuebas United States	5	235 0.7×	69 0.6×	19 0.4×	135 2.9×	23 0.7×	5	338

Countries citing papers authored by Gérald Gavory

Since Specialization

Citations

This map shows the geographic impact of Gérald Gavory's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gérald Gavory with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gérald Gavory more than expected).

Fields of papers citing papers by Gérald Gavory

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gérald Gavory. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gérald Gavory. The network helps show where Gérald Gavory may publish in the future.

Co-authorship network of co-authors of Gérald Gavory

This figure shows the co-authorship network connecting the top 25 collaborators of Gérald Gavory. A scholar is included among the top collaborators of Gérald Gavory based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gérald Gavory. Gérald Gavory is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Wappett, Mark, Julien Daubriac, Ian Lobb, et al.. (2024). USP7 inhibitors suppress tumour neoangiogenesis and promote synergy with immune checkpoint inhibitors by downregulating fibroblast VEGF. Clinical and Translational Medicine. 14(4). e1648–e1648. 9 indexed citations

Stevenson, Leanne, Xiaodun Li, Sriganesh Jammula, et al.. (2024). Inhibition of AKT enhances chemotherapy efficacy and synergistically interacts with targeting of the Inhibitor of apoptosis proteins in oesophageal adenocarcinoma. Scientific Reports. 14(1). 32121–32121.

Page, Natalie, Mark Wappett, C. O'Dowd, et al.. (2022). Identification and development of a subtype-selective allosteric AKT inhibitor suitable for clinical development. Scientific Reports. 12(1). 15715–15715. 8 indexed citations

O'Dowd, C., Gérald Gavory, Tim J. Harrison, et al.. (2019). Abstract 4423: Antitumor activity of the novel oral highly selective Wee1 inhibitor Debio 0123. Cancer Research. 79(13_Supplement). 4423–4423. 5 indexed citations

O'Dowd, C., Matthew Helm, Jakub Flasz, et al.. (2018). Identification and Structure-Guided Development of Pyrimidinone Based USP7 Inhibitors. ACS Medicinal Chemistry Letters. 9(3). 238–243. 50 indexed citations

Gavory, Gérald, C. O'Dowd, Matthew Helm, et al.. (2017). Discovery and characterization of highly potent and selective allosteric USP7 inhibitors. Nature Chemical Biology. 14(2). 118–125. 165 indexed citations

Gavory, Gérald, C. O'Dowd, Stephanie G. Burton, et al.. (2016). Abstract LB-159: A novel, potent and selective inhibitor of Wee1 with robust antitumor activity in various cancer xenograph models. Cancer Research. 76(14_Supplement). LB–159. 1 indexed citations

Matchett, Kyle B., Ivan Grishagin, Laura M. Kettyle, et al.. (2016). Mebendazole: A candidate FDA approved drug for repurposing in leukaemia. Research Portal (Queen's University Belfast). 2 indexed citations

Gavory, Gérald, C. O'Dowd, Keeva McClelland, et al.. (2015). Abstract LB-257: Discovery and characterization of novel, highly potent and selective USP7 inhibitors. Cancer Research. 75(15_Supplement). LB–257. 2 indexed citations

10.

Gavory, Gérald & Shankar Balasubramanian. (2013). PNA and Oligonucleotide Inhibitors of Human Telomerase. 1 indexed citations

11.

Roscilli, Giuseppe, Gérald Gavory, Stefania Lamartina, et al.. (2010). Abstract 685: PARP inhibitor MK-4827 is synthetic lethal for tumors with homologous recombination defects associated with ATM-deficiency, PTEN-deletion and microsatellite instability (MSI). Cancer Research. 70(8_Supplement). 685–685. 1 indexed citations

12.

Gavory, Gérald, et al.. (2006). Structural Analysis of the Catalytic Core of Human Telomerase RNA by FRET and Molecular Modeling^,. Biochemistry. 45(44). 13304–13311. 23 indexed citations

13.

Isalan, Mark, et al.. (2004). Inhibition of Human Telomerase Activity by an Engineered Zinc Finger Protein that Binds G-Quadruplexes. Biochemistry. 43(42). 13452–13458. 43 indexed citations

14.

Shammas, Masood A., Xiaohai Liu, Gérald Gavory, et al.. (2004). Targeting the single-strand G-rich overhang of telomeres with PNA inhibits cell growth and induces apoptosis of human immortal cells. Experimental Cell Research. 295(1). 204–214. 21 indexed citations

15.

Gavory, Gérald, et al.. (2002). Site-specific cleavage of human telomerase RNA using PNA-neocuproine·Zn(ii) derivatives. Chemical Communications. 36–37. 25 indexed citations

16.

Gavory, Gérald. (2002). Minimum length requirement of the alignment domain of human telomerase RNA to sustain catalytic activity in vitro. Nucleic Acids Research. 30(20). 4470–4480. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact